{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:49:59Z","timestamp":1792028999333,"version":"4.4.0"},"reference-count":122,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Community-acquired pneumonia (CAP) is among the most common causes of death and one of the leading healthcare concerns worldwide. It can evolve into sepsis and septic shock, which have a high mortality rate, especially in critical patients and comorbidities. The definitions of sepsis were revised in the last decade as \u201clife-threatening organ dysfunction caused by a dysregulated host response to infection\u201d. Procalcitonin (PCT), C-reactive protein (CRP), and complete blood count, including white blood cells, are among the most commonly analyzed sepsis-specific biomarkers also used in pneumonia in a broad range of studies. It appears to be a reliable diagnostic tool to expedite care of these patients with severe infections in the acute setting. PCT was found to be superior to most other acute phase reactants and indicators, including CRP as a predictor of pneumonia, bacteremia, sepsis, and poor outcome, although conflicting results exist. In addition, PCT use is beneficial to judge timing for the cessation of antibiotic treatment in most severe infectious states. The clinicians should be aware of strengths and weaknesses of known and potential biomarkers in expedient recognition and management of severe infections. This manuscript is intended to present an overview of the definitions, complications, and outcomes of CAP and sepsis in adults, with special regard to PCT and other important markers.<\/jats:p>","DOI":"10.3390\/diagnostics13111869","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T16:16:04Z","timestamp":1685204164000},"page":"1869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8470-8529","authenticated-orcid":false,"given":"Sedat","family":"Ozbay","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Sivas Numune Education and Research Hospital, Sivas 58040, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-2609","authenticated-orcid":false,"given":"Mustafa","family":"Ayan","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Sivas Numune Education and Research Hospital, Sivas 58040, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7623-504X","authenticated-orcid":false,"given":"Orhan","family":"Ozsoy","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Sivas Numune Education and Research Hospital, Sivas 58040, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3427-5649","authenticated-orcid":false,"given":"Canan","family":"Akman","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Canakkale Onsekiz Mart University, Canakkale 17100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-6164","authenticated-orcid":false,"given":"Ozgur","family":"Karcioglu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Health Sciences, Taksim Education and Research Hospital, Beyoglu, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/23744235.2017.1399316","article-title":"Management of community-acquired pneumonia in immunocompetent adults: Updated Swedish guidelines 2017","volume":"50","author":"Athlin","year":"2018","journal-title":"Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1155\/2005\/672501","article-title":"Epidemiology of community-acquired pneumonia in Edmonton, Alberta: An emergency department-based study","volume":"12","author":"Marrie","year":"2005","journal-title":"Can. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1034\/j.1399-3003.2000.15d21.x","article-title":"Epidemiology of community-acquired pneumonia in adults: A population-based study","volume":"15","author":"Almirall","year":"2000","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thx.2008.109785","article-title":"New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality","volume":"64","author":"Ewig","year":"2009","journal-title":"Thorax"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0032-1310103","article-title":"The burden of pneumococcal pneumonia\u2014Experience of the German competence network CAPNETZ","volume":"66","author":"Pletz","year":"2012","journal-title":"Pneumologie"},{"key":"ref_8","first-page":"119","article-title":"Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study","volume":"58","author":"Bayraktar","year":"2010","journal-title":"Tuberk. Toraks."},{"key":"ref_9","first-page":"523","article-title":"Investigation of bacterial etiology with conventional and multiplex PCR methods in adult patients with community-acquired pneumonia","volume":"46","author":"Kurutepe","year":"2012","journal-title":"Mikrobiyol. Bul."},{"key":"ref_10","first-page":"1","article-title":"Community-Acquired Pneumonia Data in Turkey","volume":"2","author":"Bulbul","year":"2014","journal-title":"G\u00fcncel G\u00f6\u011f\u00fcs Hast. Serisi"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5152\/TurkThoracJ.2021.20223","article-title":"The Role of Pneumococcal Pneumonia among Community-Acquired Pneumonia in Adult Turkish Population: TurkCAP Study","volume":"22","author":"Cilli","year":"2021","journal-title":"Turk. Thorac. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3855\/jidc.14881","article-title":"Predictors of Long-term Outcomes in the Older Adults with Community-Acquired Pneumonia","volume":"15","author":"Surme","year":"2021","journal-title":"J. Infect. Dev. Ctries"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1378\/chest.13-0062","article-title":"Impact of age and comorbidity on cause and outcome in community-acquired pneumonia","volume":"144","author":"Polverino","year":"2013","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2019.10.101","article-title":"Rates of hospitalization for community-acquired pneumonia among US adults: A systematic review","volume":"38","author":"McLaughlin","year":"2020","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ochoa-Gondar, O., Vila-C\u00f3rcoles, A., de Diego, C., Arija, V., Maxenchs, M., Grive, M., Martin, E., Pinyol, J.L., and EVAN-65 Study Group (2008). The burden of community-acquired pneumonia in the elderly: The Spanish EVAN-65 study. BMC Public Health, 8.","DOI":"10.1186\/1471-2458-8-222"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.rmed.2008.08.006","article-title":"Epidemiology of community-acquired pneumonia in older adults: A population-based study","volume":"103","year":"2009","journal-title":"Respir. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1700434","DOI":"10.1183\/13993003.00434-2017","article-title":"Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study","volume":"50","author":"Moore","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/18.4.501","article-title":"Community-acquired pneumonia","volume":"18","author":"Marrie","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01591354","article-title":"Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia","volume":"15","author":"Bohte","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/648678","article-title":"Etiology of community-acquired pneumonia: Increased microbiological yield with new diagnostic methods","volume":"50","author":"Johansson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/00365540903552353","article-title":"Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores","volume":"42","author":"Holmberg","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/14656566.2017.1340940","article-title":"Pharmacotherapy for community-acquired pneumonia in the elderly","volume":"18","author":"Viasus","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/RTI.0000000000000347","article-title":"Imaging of Community-acquired Pneumonia","volume":"33","author":"Franquet","year":"2018","journal-title":"J. Thorac. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1259\/bjr\/15037569","article-title":"Comparison of plain chest radiography and high-resolution CT in human immunodeficiency virus infected patients with community-acquired pneumonia: A sub-Saharan Africa study","volume":"80","author":"Nyamande","year":"2007","journal-title":"Br. J. Radiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.201501-0017OC","article-title":"Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia","volume":"192","author":"Claessens","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_26","first-page":"e13602","article-title":"Comparison of High-Resolution Computed Tomography and Real-Time Reverse Transcriptase Polymerase Chain Reaction in Diagnosis of COVID-19 Pneumonia in Intensive Care Unit Population","volume":"13","author":"Murtaza","year":"2021","journal-title":"Cureus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e5713","DOI":"10.1097\/MD.0000000000005713","article-title":"Lung ultrasound for the diagnosis of pneumonia in adults: A meta-analysis","volume":"96","author":"Long","year":"2017","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chest.2016.10.039","article-title":"Accuracy of Lung Ultrasonography in the Diagnosis of Pneumonia in Adults: Systematic Review and Meta-Analysis","volume":"151","year":"2017","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e061023","DOI":"10.1136\/bmjopen-2022-061023","article-title":"Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: A systematic review and duration-effect meta-analysis","volume":"13","author":"Furukawa","year":"2023","journal-title":"BMJ Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.1997.03550170070035","article-title":"Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination","volume":"278","author":"Metlay","year":"1997","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/421497","article-title":"Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia","volume":"39","author":"Musher","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","first-page":"446","article-title":"Limited usefulness of initial blood cultures in community acquired pneumonia","volume":"21","author":"Corbo","year":"2004","journal-title":"Emerg. Med. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1378\/chest.108.4.932","article-title":"Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks","volume":"108","author":"Chalasani","year":"1995","journal-title":"Chest"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ccm.2011.05.011","article-title":"New diagnostic tests for pneumonia: What is their role in clinical practice?","volume":"32","author":"File","year":"2011","journal-title":"Clin. Chest Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3343\/alm.2012.32.2.133","article-title":"Comparison of sputum and nasopharyngeal swab specimens for molecular diagnosis of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila","volume":"32","author":"Cho","year":"2012","journal-title":"Ann. Lab. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/431588","article-title":"Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction","volume":"41","author":"Templeton","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1574-6968.2010.02044.x","article-title":"Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae","volume":"310","author":"Park","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.clinthera.2009.06.010","article-title":"Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection","volume":"31","author":"Resti","year":"2009","journal-title":"Clin. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13613-016-0204-y","article-title":"Sepsis-3 definitions predict ICU mortality in a low\u2013middle-income country","volume":"6","author":"Besen","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"306-e1","DOI":"10.1016\/j.cmi.2017.07.007","article-title":"Admission lactate predicts poor prognosis independently of the CRB\/CURB-65 scores in community-acquired pneumonia","volume":"24","author":"Frenzen","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/s00134-007-0680-5","article-title":"Occult hypoperfusion and mortality in patients with suspected infection","volume":"33","author":"Howell","year":"2007","journal-title":"Intensive Care Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_44","unstructured":"Vargun, P., Yilmaz, S., Tatliparmak, A.C., and Karcioglu, O. (2023). Should lactate levels be combined with rapid emergency medicine scores (REMS) to predict outcomes of patients with dyspnea. Signa Vitae, 19."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.4187\/respcare.03953","article-title":"Predicting the Outcomes of Subjects with Severe Community-Acquired Pneumonia Using Monocyte Human Leukocyte Antigen-DR","volume":"60","author":"Zhuang","year":"2015","journal-title":"Respir. Care"},{"key":"ref_46","first-page":"547","article-title":"Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care","volume":"57","author":"Holm","year":"2007","journal-title":"Br. J. Gen. Pract."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00134-005-0047-8","article-title":"Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia","volume":"32","author":"Boussekey","year":"2006","journal-title":"Intensive Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"f2450","DOI":"10.1136\/bmj.f2450","article-title":"Grace Consortium. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: Diagnostic study","volume":"346","author":"Broekhuizen","year":"2013","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thx.2008.105312","article-title":"Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia","volume":"64","author":"Reyes","year":"2009","journal-title":"Thorax"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/acem.13889","article-title":"Accuracy of Biomarkers for the Diagnosis of Adult Community-acquired Pneumonia: A Meta-analysis","volume":"27","author":"Ebell","year":"2020","journal-title":"Acad. Emerg. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Parke, \u00c5., Unge, C., Yu, D., Sund\u00e9n-Cullberg, J., and Str\u00e5lin, K. (2023). Plasma calprotectin as an indicator of need of transfer to intensive care in patients with suspected sepsis at the emergency department. BMC Emerg. Med., 23.","DOI":"10.1186\/s12873-023-00785-y"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3904\/kjim.2013.28.3.285","article-title":"Procalcitonin as a biomarker of infectious diseases","volume":"28","author":"Lee","year":"2013","journal-title":"Korean J. Intern. Med."},{"key":"ref_53","first-page":"S57","article-title":"Physiology and genetics of procalcitonin","volume":"49","author":"Maruna","year":"2000","journal-title":"Physiol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1097\/00003246-200209000-00023","article-title":"Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells","volume":"30","author":"Hoffmann","year":"2002","journal-title":"Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40560-017-0246-8","article-title":"Procalcitonin: A promising diagnostic marker for sepsis and antibiotic therapy","volume":"5","author":"Vijayan","year":"2017","journal-title":"J. Intensive Care"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Philipp, S., Werner, A., and Beat, M. (2011). Procalcitonin for diagnosis of infection and guide to antibiotic decisions: Past, present and future. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-107"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"23194","DOI":"10.1038\/s41598-021-02679-0","article-title":"Procalcitonin metabolomics in the critically ill reveal relationships between inflammation intensity and energy utilization pathways","volume":"11","author":"Kobayashi","year":"2021","journal-title":"Sci Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.idc.2012.11.003","article-title":"Biomarkers: What is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia?","volume":"27","author":"Upadhyay","year":"2013","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14737159.2018.1407244","article-title":"Novel applications for serum procalcitonin testing in clinical practice","volume":"18","author":"Choi","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial","volume":"174","author":"Stolz","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","article-title":"Procalcitonin increase in early identification of critically ill patients at high risk of mortality","volume":"34","author":"Jensen","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3109\/00365548.2014.945955","article-title":"Procalcitonin levels in community-acquired pneumonia-correlation with aetiology and severity","volume":"46","author":"Johansson","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1515\/cclm-2016-0705","article-title":"Comparison between procalcitonin and C-reactive protein in predicting bacteremias and confounding factors: A case-control study","volume":"55","author":"Nishikawa","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Nouvenne, A., Ticinesi, A., Folesani, G., Cerundolo, N., Prati, B., Morelli, I., Guida, L., Lauretani, F., Maggio, M., and Aloe, R. (2016). The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: Retrospective cohort study. BMC Geriatr., 16.","DOI":"10.1186\/s12877-016-0192-7"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"923457","DOI":"10.3389\/fpubh.2022.923457","article-title":"The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"741268","DOI":"10.3389\/fimmu.2021.741268","article-title":"Diagnostic Value of sIL-2R, TNF-\u03b1 and PCT for Sepsis Infection in Patients with Closed Abdominal Injury Complicated with Severe Multiple Abdominal Injuries","volume":"12","author":"Zhai","year":"2021","journal-title":"Front Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/COPD.S122382","article-title":"Determining prognosis in acute exacerbation of COPD","volume":"12","author":"Flattet","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"160073","DOI":"10.1183\/16000617.0073-2016","article-title":"Procalcitonin to guide antibiotic administration in COPD exacerbations: A meta-analysis","volume":"26","author":"Mathioudakis","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2147\/COPD.S104051","article-title":"Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD","volume":"11","author":"Corti","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: A randomized, controlled trial comparing procalcitonin-guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"566","DOI":"10.12669\/pjms.333.12554","article-title":"Values of procalcitonin and C-reactive proteins in the diagnosis and treatment of chronic obstructive pulmonary disease having concomitant bacterial infection","volume":"33","author":"Li","year":"2017","journal-title":"Pak. J. Med. Sci."},{"key":"ref_72","first-page":"1178633719852626","article-title":"Introduction of Procalcitonin Testing and Antibiotic Utilization for acute exacerbations of chronic obstructive pulmonary disease","volume":"12","author":"Ulrich","year":"2019","journal-title":"Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/2452-2473.329630","article-title":"2021 Guideline for the Management of COPD Exacerbations: Emergency Medicine Association of Turkey (EMAT)\/Turkish Thoracic Society (TTS) Clinical Practice Guideline Task Force","volume":"21","author":"Varol","year":"2021","journal-title":"Turk. J. Emerg. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Molinero-Fern\u00e1ndez, \u00c1., Moreno-Guzm\u00e1n, M., L\u00f3pez, M.\u00c1., and Escarpa, A. (2020). Magnetic bead-based electrochemical immunoassays on-drop and on-chip for procalcitonin determination: Disposable tools for clinical sepsis diagnosis. Biosensors, 10.","DOI":"10.3390\/bios10060066"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.emc.2013.07.009","article-title":"Fever and signs of shock: The essential dangerous fever","volume":"31","year":"2013","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tsui, T.L., Huang, Y.T., Kan, W.C., Huang, M.S., Lai, M.Y., Ueng, K.C., and Shiao, C.C. (2021). A novel procalcitonin-based score for detecting sepsis among critically ill patients. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245748"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/ijcp.12278","article-title":"Diagnostic value of procalcitonin for bacterial infection in elderly patients\u2014A systemic review and meta-analysis","volume":"67","author":"Lee","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40520-015-0500-7","article-title":"Are prognostic scores and biomarkers such as procalcitonin the appropriate prognostic precursors for elderly patients with sepsis in the emergency department?","volume":"28","author":"Lee","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4187\/respcare.02741","article-title":"C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia","volume":"59","author":"Porfyridis","year":"2014","journal-title":"Respir. Care"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ejhf.443","article-title":"Optimizing clinical use of biomarkers in high-risk acute heart failure patients","volume":"18","author":"Demissei","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2015.11.141","article-title":"Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients","volume":"204","author":"Demissei","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jinf.2013.10.003","article-title":"Description and predictive factors of infection in patients with chronic kidney disease admitted to the critical care unit","volume":"68","author":"Contou","year":"2014","journal-title":"J. Infect."},{"key":"ref_83","first-page":"33","article-title":"Inflammation markers, chronic kidney disease, and renal replacement therapy","volume":"27","year":"2011","journal-title":"Adv. Perit. Dial."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11255-013-0542-8","article-title":"Procalcitonin: Diagnostic value in systemic infections in chronic kidney disease or renal transplant patients","volume":"46","author":"Dumea","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/cid\/ciu732","article-title":"Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy","volume":"59","author":"Grace","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ndt\/gfs339","article-title":"Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: A systematic review and meta-analysis","volume":"28","author":"Lu","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ndt\/16.5.980","article-title":"Procalcitonin: A new marker of inflammation in haemodialysis patients?","volume":"16","author":"Level","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3904\/kjim.2015.30.2.198","article-title":"Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients","volume":"30","author":"Lee","year":"2015","journal-title":"Korean J. Intern. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00467-006-0304-2","article-title":"Procalcitonin serum levels in children undergoing chronic haemodialysis","volume":"22","author":"Lorton","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7754\/Clin.Lab.2015.150736","article-title":"Procalcitonin, an independent marker of abdominal fat accumulation in obese patients","volume":"62","author":"Boursier","year":"2016","journal-title":"Clin. Lab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1542\/hpeds.2018-0123","article-title":"Procalcitonin as a Predictive Marker for Bacteremia in Children with a Central Line and Fever","volume":"9","author":"Damman","year":"2019","journal-title":"Hosp. Pediatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1542\/hpeds.2020-001842","article-title":"Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification","volume":"11","author":"Sartori","year":"2021","journal-title":"Hosp. Pediatr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e01851-19","DOI":"10.1128\/JCM.01851-19","article-title":"Utility of Procalcitonin as a Biomarker for Sepsis in Children","volume":"58","author":"Downes","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/cc13760","article-title":"Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: A prospective cohort study, systematic review and individual patient data meta-analysis","volume":"18","author":"Pfister","year":"2014","journal-title":"Crit. Care"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOP.0b013e328341ebd9","article-title":"Diagnostic tests for influenza infection","volume":"23","author":"Landry","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (2012). Evaluation of 11 commercially available rapid influenza diagnostic tests\u2014United States, 2011\u20132012. MMWR Morb. Mortal. Wkly. Rep., 61, 873.","DOI":"10.1016\/j.annemergmed.2013.03.012"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1750-2659.2012.00386.x","article-title":"Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis","volume":"7","author":"Wu","year":"2013","journal-title":"Influenza. Other Respir. Viruses"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jinf.2015.11.007","article-title":"Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis","volume":"72","author":"Schuetz","year":"2016","journal-title":"J. Infect."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/j.ijid.2012.01.003","article-title":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza","volume":"16","author":"Metersky","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1086\/652291","article-title":"Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza","volume":"50","author":"Jean","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/infdis\/jir861","article-title":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection","volume":"205","author":"Paddock","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.34512","article-title":"Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: A systematic review and meta-analysis","volume":"64","author":"Wu","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3810\/pgm.2014.03.2737","article-title":"The hospitalist perspective on treatment of community-acquired bacterial pneumonia","volume":"126","author":"Amin","year":"2014","journal-title":"Postgrad. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jgar.2022.12.010","article-title":"Oral vs. parenteral antibiotic therapy in adult patients with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials","volume":"32","author":"Teng","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/thoraxjnl-2019-214054","article-title":"Empiric antibiotics for community-acquired pneumonia in adult patients: A systematic review and a network meta-analysis","volume":"76","author":"Tinoco","year":"2021","journal-title":"Thorax"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/ciac615","article-title":"Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"76","author":"Choi","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jiac.2022.04.020","article-title":"Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials","volume":"28","author":"Ashy","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3000605211049943","DOI":"10.1177\/03000605211049943","article-title":"Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: A systematic review","volume":"49","author":"Gillani","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jgar.2020.08.005","article-title":"Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Lan","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial","volume":"16","author":"Beishuizen","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1164\/rccm.202004-1201OC","article-title":"Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial","volume":"203","author":"Kyriazopoulou","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/ciw217","article-title":"Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14787210.2018.1496331","article-title":"Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials","volume":"16","author":"Schuetz","year":"2018","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_116","first-page":"CD012252","article-title":"Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: An overview of systematic reviews","volume":"9","author":"Suijkerbuijk","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1440-1843.2011.01978.x","article-title":"Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia","volume":"16","author":"Long","year":"2011","journal-title":"Respirology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"n2132","DOI":"10.1136\/bmj.n2132","article-title":"Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: Pragmatic cluster randomised trial","volume":"374","author":"Lhopitallier","year":"2021","journal-title":"BMJ"},{"key":"ref_119","unstructured":"Rhee, C., and Mansour, M.K. (2023, March 28). Procalcitonin Use in Lower Respiratory Tract Infections. UpToDate\u00ae 2023 UpToDate, Inc. Available online: https:\/\/www.uptodate.com\/contents\/procalcitonin-use-in-lower-respiratory-tract-infections\/abstract\/83."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations","volume":"36","author":"Becker","year":"2008","journal-title":"Crit. Care Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2362.2010.02259.x","article-title":"Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: A retrospective cohort study","volume":"40","author":"Schuetz","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nm0712-999","article-title":"New biomarkers sought for improving sepsis management and care","volume":"18","author":"Moyer","year":"2012","journal-title":"Nat. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/11\/1869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:43:12Z","timestamp":1760125392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/11\/1869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":122,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["diagnostics13111869"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13111869","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]}}}